Back to School: How biopharma can reboot drug development. Access exclusive analysis here

HCT-3012: Began Phase I trial

NicOx S.A. (NM:Nicox), Sophia-Antipolis, France
Product:

Read the full 67 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE